Nu-Med Plus (NUMD) Cash & Current Investments (2011 - 2025)
Nu-Med Plus' (NUMD) quarterly Cash & Current Investments came in at $661.0 in Q4 2025, down 72.14% year-on-year from $2373.0 in Q4 2024, and down 66.07% quarter-over-quarter from $1948.0 in Q3 2025.
Nu-Med Plus (NUMD) Cash & Current Investments (2011 - 2025) Analysis & Trends
Nu-Med Plus has disclosed Cash & Current Investments across 15 years of filings, most recently posting $661.0 for Q4 2025.
- Cash & Current Investments for Q4 2025 came in at $661.0, down 72.14% year-over-year; the trailing twelve-month figure through Dec 2025 was $661.0 (down 72.14% YoY), and the FY2025 annual result was $661.0, down 72.14% from the prior year.
- Cash & Current Investments came in at $661.0 for Q4 2025 at Nu-Med Plus, down from $1948.0 in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $139265.0 in Q1 2021 to a low of $628.0 in Q3 2022.
- The 5-year median for Cash & Current Investments is $6356.0 (2024), against an average of $23974.1.
- Across the five-year window, Cash & Current Investments sank 98.18% in 2022 and jumped 1990.22% in 2023, its largest moves.
- Nu-Med Plus' Cash & Current Investments stood at $11675.0 in 2021, then soared by 526.94% to $73195.0 in 2022, then slumped by 90.7% to $6806.0 in 2023, then tumbled by 65.13% to $2373.0 in 2024, then slumped by 72.14% to $661.0 in 2025.
- The last three Cash & Current Investments figures came in at $661.0 (Q4 2025), $1948.0 (Q3 2025), and $863.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 8.38 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.12 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1.12 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 439.60 Mn |
| 10 | Nu-Med Plus | - | - | - | 661.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 661.00 |
| Sep 30, 2025 | 1,948.00 |
| Jun 30, 2025 | 863.00 |
| Mar 31, 2025 | 2,373.00 |
| Dec 31, 2024 | 2,373.00 |
| Sep 30, 2024 | 4,041.00 |
| Jun 30, 2024 | 4,041.00 |
| Mar 31, 2024 | 6,356.00 |
| Dec 31, 2023 | 6,806.00 |
| Sep 30, 2023 | 11,088.00 |
| Jun 30, 2023 | 29,957.00 |
| Mar 31, 2023 | 53,029.00 |
| Dec 31, 2022 | 73,195.00 |
| Sep 30, 2022 | 628.00 |
| Mar 31, 2022 | 2,537.00 |
| Dec 31, 2021 | 11,675.00 |
| Sep 30, 2021 | 31,840.00 |
| Jun 30, 2021 | 72,831.00 |
| Mar 31, 2021 | 139,265.00 |
| Dec 31, 2020 | 188,506.00 |